Related Experiment Video
Updated: Jul 12, 2026
09:49
Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
Published on: July 5, 2019
Mediastinal epithelial neoplasms with recurrent molecular alterations.
Michael W Mikula1, Ezra Baraban1
1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Mediastinum (Hong Kong, China)
|July 10, 2026
Summary
This review details recurrent molecular genetic alterations in mediastinal epithelial tumors, aiding pathologists in recognizing molecularly defined entities and their genetic basis. Understanding these alterations is crucial for diagnosis and prognosis of aggressive tumors.
Area of Science:
- Oncology
- Pathology
- Genetics
Background:
- Mediastinal epithelial tumors encompass a range of benign and malignant neoplasms.
- Accurate diagnosis and prognostication are essential due to the aggressive behavior of some subtypes.
Purpose of the Study:
- To review recurrent molecular genetic alterations in mediastinal epithelial tumors.
- To aid surgical pathologists in recognizing molecularly defined entities and their genetic underpinnings.
- To highlight diagnostically useful immunohistochemical targets.
Main Methods:
- Review of molecular landscape of thymoma and thymic carcinoma.
- Analysis of molecular classification schemes and common alterations from The Cancer Genome Atlas and other sources.
- Discussion of specific entities like NUT carcinoma and SWI/SNF complex-deficient tumors.
Main Results:
- Identification of recurrent molecular genetic alterations in various mediastinal epithelial tumors.
- Correlation of molecular alterations with prognostic and therapeutic implications.
- Description of challenging morphologic and immunohistochemical profiles of poorly differentiated neoplasms.
Conclusions:
- Molecular insights are critical for understanding and diagnosing mediastinal epithelial tumors.
- Recognition of specific molecular alterations aids in identifying aggressive tumors like NUT carcinoma and SWI/SNF complex-deficient tumors.
- Further understanding of genetic events is needed for these destructive tumors.
Related Concept Videos
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:24Cellular Adaptation IV: Dysplasia and Metaplasia
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
03:18Non-LTR Retrotransposons
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...